Basf Aktiengesellschaft

Basf Se Corporation

Fraunhofer-gesellschaft Zur Foerderung Der Angewandten Forschung E.v.

Basfaktiengesellschaft

Basf Aktienegesellschaft

Basf Aktiengeselschaft

Axel Sanner

Son Nguyen Kim

Volker Schehlmann

Karl Kolter

Jorg Breitenbach

Stephan Kothrade

Peter H&ouml;ssel

Karin Sperling-Vietmeier

Sven Grabowski

Reinhold Dieing

Maximilian Angel

Gunther Berndl

Helmut Meffert

Rainer Blankenburg

Christian Schade

Joerg Rosenberg

Adolf Nuber

Franz Frosch

Peter Hössel

Walter Denzinger

Birgit Potthoff-Karl

Siegfried Lang

Hans-Helmut Goertz

Stefan Stein

Hans-Ulrich Wekel

Folker Ruchatz

Michael Gotsche

Hans-Josef Sterzel

Chung-Ji Tschang

Karin Sperling

Peter Hossel

Friedrich Vogel

Katrin Zeitz

Harald Meyer

Helmut B Witteler

Horst Westenfelder

Roger G Klimesch

Hans-Juergen Raubenheimer

Ferdinand Straub

Albert Elzer

Wilma M Dausch

Stefan Marcinowski

Heinrich Hartmann

Rolf Fikentscher

Gunnar Schornick

Matthias Kroner

Kurt H Bauer

Norbert Greif

Dirk Simon

J&ouml;rg Breitenbach

Alfred Leinenbach

Karin Neubecker

Albrecht Eckell

Reinhard Spengler

Hans J Richter

Reiner Hofmann

Peter Neumann

Rainer Becker

Erich Beck

Bernd Wolf

Christoph Kuenast

Reinhold J Leyrer

Hans Theobald

Peter Hofmeister

August Lehner

Werner Lenz

Frank Dietsche

Adolf Parg

Juergen Detering

Joachim Roser

Manfred Niessner

Helmut Barzynski

Hans-Uwe Schenck

Hans Schupp

Kristin Tiefensee

Claudia Nilz

Harald Lauke

Thomas Loerzer

Anton Hesse

Kurt Wendel

Wolfgang Ladner

Herbert Fisch

John-Bryan Speakman

Dieter Urban

Bernhard Fussnegger

Jörg Breitenbach

Jürgen Tropsch

Lothar Schlemmer

Gerhard Bleckmann

Heinrich Sack

Peter Richter

Keith Leslie Rutherford

Mathias Hahn

Hermann Fischer

Werner Jaeger

Karl Seib

Anton Negele

Jens Rieger

Peter Hoessel

Loni Schweikert

The invention relates to excipients in powder form for use in solid pharmaceutical presentations, comprising a pharmaceutically acceptable polymer and a liquid or semisolid solubilizing surface-active substance.

Solubilizing aids in powder form for solid pharmaceutical presentation forms

The present invention relates to crosslinked, water-soluble or water-dispersible polyurethanes of

Crosslinked, water-soluble or water-dispersible polyurethanes

The use of copolymers obtainable by the radically initiated polymerization of A) 50 to 99.9 wt % of an olefinically unsaturated C3 to C5 monocarboxylic acid, an olefinically unsaturated C4 to C8 dicarboxylic acid or its anhydride, or a mixture of such carboxylic acids or carboxylic acid anhydrides with B) 0.1 to 50 wt % of one or more long-chained compounds with isolated multiple C&#x2014;C bonds from the group (1) mono or polyunsaturated C8 to C30 monocarboxylic acids which may have additional hydroxyl groups and their alkaline metal and earth alkaline metal salts, alkyl esters, amides, sorbitane esters, glycerin esters and polyglycerin esters, (2) mono or polyunsaturated aliphatic Ca to C30 amines, (3) mono or polyunsaturated C8 to C30 alcohols and esters thereof with saturated Cl to C4 monocarboxylic acids, (4) to (C8 to C30 alkyl) vinyl ether which may incorporate up to 25 alkylene oxide units, and (5) final and medium-position Ci3 to C30 alkenes; C) 0 to 49.9 wt % of other copolymerizable monomers, and D) 0 to 10 wt % of one or more compounds with at least two olefinically unsaturated groups in the molecule as cross-linking agents, as thickening or dispersing agents, especially in cosmetic and pharmaceutical preparations.

Use of copolymers of carboxylic acids and long-chain compounds with isolated C-C multiple bonds as thickeners or dispersants

The invention relates to the use of at least one copolymer obtainable by

Use of crosslinked cationic polymers in skin cosmetic and dermatological preparations

Solid dosage forms containing at least one polymer binder, at least one active ingredient and, where appropriate, conventional additives, wherein a physiologically tolerated, water-swellable graft copolymer or a mixture of graft copolymers is employed as polymeric binder.

Process for producing solid dosage forms

The present invention relates to the use of copolymers A containing

Use of hydrophobically modified copolymers based on N-vinyl monomers for the production of membranes

The present invention relates to quaternized polyamidoamines which have at least one structural unit of the formula VII  The invention also relates to the preparation of the quaternary polyamidoamines, to compositions which comprise these compounds, and to the use thereof for cosmetic and pharmaceutical purposes, and in the fields of crop protection and textile dyeing. The present invention also relates to the use of quaternized polyamidoamines of the ionene type as biostatic or biocide and thus also biocidal compositions based on quaternized polyamidoamines.

Quaternary polyamidoamines, the production thereof, corresponding agents and the use thereof

The present invention relates to water-soluble or water-dispersible copolymers obtainable by free-radical polymerization of 

Water-soluble or water-dispersible (co) polymers of hydroxyalkyl (meth) acrylates, a process for their preparation, and their use as coating agent, binder and/or film-forming excipient pharmaceutical dosage forms

A process for producing solid dosage forms by mixing at least one polymer binder, at least one active ingredient and, where appropriate, conventional additives to form a plastic mixture, and shaping, wherein a physiologically tolerated, water-swellable graft copolymer or a mixture of graft copolymers is employed as polymeric binder.

Cationic polyurethanes and polyureas formed from

Water-soluble or water-dispersible graft polymers, their preparation and use

The use of polymers obtainable by free-radical polymerization of

Formulations of hair cosmetics

Compositions comprising at least one water-insoluble ingredient and at least one copolymer of

Compositions comprising copolymers of N-vinylcarboxamides and monomers with a hydrophobic radical, and use of these copolymers

A cosmetic composition comprising at least one water-soluble or water-dispersible polymer which comprises, in copolymerized form,

Cosmetic composition with water-soluble or water-dispersible polymers

Graft polymers are used as gas hydrate inhibitors.

Grafted polymers as gas hydrate inhibitors

Growing community of inventors

Frankenthal, Germany

Axel Sanner